Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
10
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 10 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Epinephrine Epinephrine | D | $119M | -11% | 458,644 | $260 | $99.63 |
| Auvi-Q Epinephrine | D | $713K | -1% | 876 | $814 | $300.57 |
| Neffy Epinephrine | D | $210K | n/a | 255 | $825 | $340.89 |
| Epipen 2-Pak Epinephrine | D | $167K | -81% | 243 | $689 | $291.17 |
| Adrenalin Epinephrine | D | $61K | +20% | 2,713 | $22 | $13.74 |
| Epinephrine Epinephrine HCL/PF · J0173 | B | $28K | n/a | 1,177 | $24 | $1.87 |
| Adrenalin* Epinephrine* · J0171 | B | $11K | +10% | 2,258 | $5 | $1.58 |
| Xylocaine With Epinephrine Lidocaine HCl/Epinephrine | D | $1K | +168% | 72 | $15 | $0.37 |
| Xylocaine-MPF With Epinephrine Lidocaine HCl/Epinephrine/PF | D | $438 | n/a | 11 | $40 | $0.89 |
| Lidocaine HCl-Epinephrine Lidocaine HCl/Epinephrine | D | $188 | -79% | 35 | $5 | $0.26 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.